Salvo Health Secures $8.5M in Series A Funding for Virtual Gastrointestinal Care Platform

Salvo Health did not show up with a megaphone. It showed up with a chart, a care team, and a problem most people feel before they ever understand it. Founded in 2021 and headquartered at 335 Madison Avenue in NYC, Salvo Health exists because the gut never waits for the next appointment. 60-70 Americans live with chronic GI conditions, and there are roughly 15,400 board certified gastroenterologists to serve them. That math does not digest well.

Jeff Glueck built Salvo Health after living through a personal loss that exposed how little the system learns between visits. He is not new to scale. Site59, Travelocity, and Foursquare all taught the same lesson. Systems break when they only listen once a year. Avi Dorfman saw the same fracture points building Clearing. Jason Finger learned it moving Seamless from idea to public company. Three founders, three pattern recognitions, one conclusion. Episodic care leaves too much on the table.

Salvo Health operates as a provider enablement platform, not a replacement act. It wraps around gastroenterology practices and health systems, extending care through a mobile app, asynchronous messaging, monthly virtual visits, and multidisciplinary teams that include registered dietitians, behavioral health specialists, nurses, and physicians. The platform fills the quiet weeks where symptoms actually live. The word Salvo fits. Coordinated, intentional, and sustained.

The traction is loud without being noisy. As of January 2026, Salvo Health has signed partnerships with 801 board certified GI physicians, representing 16% of independent gastroenterologists in the United States. Three of the four largest GI practice networks are already in. Patient and revenue growth ran 800% year over year in 2025. 80% of patients report feeling better within six weeks. GI related ER visits dropped 79%. Payers see three dollars saved for every dollar spent. This is not hope. It is math again.

In January 2026, Salvo Health closed an $8.5M Series A co-led by ManchesterStory, City Light Capital, and Threshold Ventures, with participation from The Artemis Fund, Contour Venture Partners, Torch Capital, Felicis Ventures, Human Ventures, and Alumni Ventures. Total funding now stands at $21.6M. The capital is earmarked for scaling provider deployment, expanding beyond nine operational states, and deepening AI enhanced workflows inside the proprietary Sano platform.

Execution matters. Marin Rothenberg built the operational spine, including licensing infrastructure across all 50 states plus Washington D.C. Erin Hendriks anchors the clinical model with integrative, obesity, and lifestyle medicine rigor. Advisory leadership from Mark Hyman, Mark Pimentel, and Emeran Mayer keeps the science honest and the gut brain conversation grounded in evidence.

Salvo Health is not trying to be everywhere. It is trying to be present between visits, inside workflows, and across outcomes that finally connect. In a market where silence costs patients and noise costs providers, the most interesting question is how loud sustained care can get when it compounds.